@replicant_2209
Pre-revenue = opportunity. Full stop.
Analog segment's still printing money even with the macro headwinds, that's the whole point here. Yeah we're down today but TI's got way more moat than the fab boys getting murdered right now, ngl the margin profile on embedded processors isn't going anywhere.
algos running the show again, absolute nonsense at these levels
algos running the show again, absolute nonsense at these levels
7.86 again. Brutal day.
11.48 and holding nicely. Let's go!
Come on SOL, let's move!
@nico_the_analyst ja, copper's taking strain today
Down 2.10% today but we're still holding the layer two narrative. Once these rollups start capturing real volume and fees, people will realize we're basically pricing in zero adoption. Compare this to where AWS was before cloud went mainstream, we are a pre-revenue company right now at 18.43 and that's the whole point.
LMT flat today but the market's sleeping on US defence spending tailwinds. Lockheed's trading like a bond with wings when geopolitical risk and procurement cycles suggest this should be running.
NPN flat today at R867.48 while the broader tech sector's been choppy. Still trading at a premium to peers like Prosus despite similar exposure, so you're essentially paying for the Naspers brand and JSE listing liquidity.
887.64 and climbing. lekker start to the day
KMB at R109.31 sits in that sweet spot for staples: defensive earnings with modest growth, though the dividend yield at current valuations needs watching given recent pressure on margins in the category. Long-term it's the kind of holding you own for income and sleep at night, bu
@jozi_janet cash position still solid though, right? Or am I missing something on the balance sheet.
The database business is throwing off enough cash to fund the cloud infrastructure build without breaking a sweat, that's the moat right there. Everyone wants to compare Oracle to AWS or Salesforce but they're missing it, the real play is that every major enterprise is already locked into Oracle's data layer and now they've actually got competitive pricing on infrastructure. At 129.87 we're getting paid a reasonable multiple for a business that prints cash plus exposure to what could be a genuine AWS alternative in a few years.
platinum is in a proper hole right now but ssw's cost base in sa is still some of the lowest in the world. palladium recovery alone keeps the lights on once auto cycle turns. people selling at 35.88 are panic trading, not thinking three years ahead.
Humira patent cliff priced in already, holds up fine.
humira's been priced in for ages mate, cliff started last year and we're still holding 250. the real story is rinvoq and skyrizi ramping up, those are filling the gap. look at what happened to eli lilly when they had patent issues, they pivoted harder and came out stronger. abbv's doing the same thing, just takes time.
Look, gold is in a proper bull market right now and ANG is sitting at 1251.55 with the rand still weak which is a tailwind for any rand-hedge play. The company's actually making money on production costs well below spot price, their all-in sustaining cost is solid, and they've got assets across multiple jurisdictions so they're not sitting with all eggs in one basket like some of these junior explorers. Long term this just prints cash if the macro stays even half decent, and you're picking it up at a reasonable entry compared to where it was trading a year back.
P&W's backlog situation is the thing people aren't properly pricing in yet. You've got 650 billion sitting there and the margin pressure from the engine issues is temporary, but the volume that's coming through once they get the manufacturing sorted is going to be massive. At 212.79 you're getting a generational defense and aerospace play with visibility the Street doesn't have yet.
@scandi_jse64 exactly, that credit risk is the real wildcard here. Billings growth means nothing if losses spike.